SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-23-000380
Filing Date
2023-06-27
Accepted
2023-06-27 17:11:49
Documents
14
Period of Report
2023-06-27
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT FOR 06-27-2023 form_8-k.htm   iXBRL 8-K 22817
2 LETTER FROM M&K CPAS, PLLC DATED JUNE 27, 2023 ex_16-1.htm EX-16 2483
3 GRAPHIC globestar_logo.jpg GRAPHIC 10744
  Complete submission text file 0001161697-23-000380.txt   227158

Data Files

Seq Description Document Type Size
4 INLINE XBRL SCHEMA FILE gstc-20230627.xsd EX-101.SCH 3018
5 INLINE XBRL LABEL FILE gstc-20230627_lab.xml EX-101.LAB 34240
6 INLINE XBRL PRESENTATION FILE gstc-20230627_pre.xml EX-101.PRE 22361
8 EXTRACTED XBRL INSTANCE DOCUMENT form_8-k_htm.xml XML 3186
Mailing Address 719 JADWIN AVENUE RICHLAND WA 99352
Business Address 719 JADWIN AVENUE RICHLAND WA 99352 509-531-1671
GlobeStar Therapeutics Corp (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-55072 | Film No.: 231048418
SIC: 2834 Pharmaceutical Preparations